MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waelbroeck, M.
Right arrow Articles by Christophe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waelbroeck, M.
Right arrow Articles by Christophe, J.

The human heart beta-adrenergic receptors. II. Coupling of beta 2- adrenergic receptors with the adenylate cyclase system

M Waelbroeck, G Taton, M Delhaye, P Chatelain, JC Camus, R Pochet, JL Leclerc, JM De Smet, P Robberecht and J Christophe

The beta-adrenergic stimulation of adenylate cyclase in membranes from human auricles, ventricles, and fetal heart was compared with the binding properties of beta-adrenergic receptors in human auricles. In terms of adenylate cyclase activation, three full agonists (isoproterenol, epinephrine, and norepinephrine), four partial agonists (procaterol, salbutamol, fenoterol, and zinterol), and four antagonists (propranolol, metoprolol, atenolol, and practolol) were tested. The beta-adrenergic activation of adenylate cyclase in membranes from rat heart (with a majority of beta 1-adrenergic receptors), rat erythrocytes, and rat reticulocytes (with a homogeneous population of beta 2-adrenergic receptors) served as reference. The reactivity of human heart adenylate cyclase, estimated by the Kact or Ki values of 11 beta-adrenergic agents, indicated that the activation of this enzyme occurred through receptors of the beta 2-subtype only. Receptors of the beta 1-subtype (50% of the total population) were not coupled to the enzyme.

Volume 24, Issue 2, pp. 174-182, 09/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
G. P. R. Clunie and L. Lennard
Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine
Rheumatology, January 1, 2004; 43(1): 13 - 18.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. W. Guerrero and K. P. Minneman
Coupling Efficiencies of beta 1- and beta 2-Adrenergic Receptors Expressed Alone or Together in Transfected GH3 Pituitary Cells
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 980 - 988.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C. Pavoine, S. Magne, A. Sauvadet, and F. Pecker
Evidence for a beta 2-Adrenergic/Arachidonic Acid Pathway in Ventricular Cardiomyocytes. REGULATION BY THE beta 1-ADRENERGIC/cAMP PATHWAY
J. Biol. Chem., January 8, 1999; 274(2): 628 - 637.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. A. Skeberdis and a. R. Fischmeister
Beta-2 Adrenergic Activation of L-Type Ca++ Current in Cardiac Myocytes
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 452 - 461.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics